Japanese Drug Makers Build Stockpiles Against Impact Of Flu Pandemic

Japanese pharmaceuticals are gearing up to add to drug stockpiles to ensure the country has two-month supplies of several drugs in case production is affected by an influenza pandemic. Mitsubishi Tanabe Pharma is creating a three-month stockpile of its blood products and treatments to treat strokes and newborn breathing problems. Eisai and Takeda are working on two-month supplies of their core products, which include Alzheimer's and cancer drugs for Eisai. Takeda is concentrating on in-demand drugs such as those for blood pressure, diabetes and prostate cancer. (Click here for more - a subscription may be required